New highly calcemic 1α,25-dihydroxy-19-norvitamin D3 compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series

Steroids

Volumn 67, Issue 3-4, 2002, Pages 247-256

  Sicinski, Rafal R ^a   Prahl, Jean M ^a   Smith, Connie M ^a   DeLuca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

19 Norvitamin D compounds; Calcemic activity; Differentiation of HL 60 cells; Vitamin D analogs; Vitamin D receptor

Indexed keywords

1ALPHA,25 DIHYDROXY 2 METHYLENE 26,27 DIHOMO 19 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 26,27 DIMETHYLENE 2 METHYLENE 19 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 26,27 DIMETHYLENE 2ALPHA METHYL 19 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 26,27 DIMETHYLENE 2BETA METHYL 19 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 2ALPHA METHYL 26,27 DIHOMO 19 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 2BETA METHYL 26,27 DIHOOMO 19 NORVITAMIN D3; CALCITRIOL; CALCITRIOL RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; SWINE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; BIOLOGICAL TRANSPORT; BONE AND BONES; CALCITRIOL; CALCIUM; CELL DIFFERENTIATION; HL-60 CELLS; HUMANS; HYDROXYLATION; INTESTINES; MAGNETIC RESONANCE SPECTROSCOPY; RECEPTORS, CALCITRIOL; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE; VITAMIN D DEFICIENCY;

SUIDAE;

EID: 0036169062     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(01)00156-8     Document Type: Article

References (35)

1. 3
2. The role of the vitamin D endocrine system in health and disease
3. The vitamin D story; a collaborative effort of basic science and clinical medicine
4. Structures and biological activities of vitamin D metabolites and their analogs
5. Structure-function relationships in the vitamin D endocrine system
6. Newly identified actions of the vitamin D endocrine system
7. 3 on the growth of soft tissue sarcoma cells as mediated by the vitamin D receptor
8. 3 in human malignant melanoma cell lines
9. 3 inhibits productive infection of human monocytes by HIV-1
10. 3-responsive protein in human lymphocytes; immunologic crossreactivity and inverse regulation with the vitamin D receptor
11. The role of vitamin D in bone and intestinal cell differentiation
12. 3 in the myeloid cell differentiation
13. The vitamin D-induced differentiation of HL-60 cells; structural requirements
14. 3; a novel immunoregulatory hormone
15. 3 and its fluorinated analogs
16. Novel synthesis of 19-nor-vitamin D compounds
17. Wisconsin Alumni Research Foundation, U.S.A. 19-Norvitamin D compounds. Eur Pat Appl EP 387,077. 1990 Sept 12
18. 3, a novel synthetic vitamin D-related compound with potential therapeutic activity
19. 3
20. 3 compounds of high biological activity; synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues
21. Osteoporosis and vitamin D
22. 3 on differentiation-inducing activity of human promyelocytic leukemia (HL-60) cells in serum-supplemented or serum-free culture
23. Chemical synthesis of vitamin D analogs with selective biological activities
24. 3
25. 3 for calcium regulating activity
26. 3
27. 3 analogue with potent non-classical effects
28. 3 analogues; a novel class of potent regulators of cell growth and immune responses
29. Immunological properties of vitamin D analogues and metabolites
30. Biological activity of 25-hydroxyergocalciferol in rats
31. 1,25-Dihydroxycholecalciferol analogs cannot replace vitamin D in normocalcemic male rats
32. Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs
33. 3; interaction with distinct receptor domains